More Women Are Choosing Breast-Conserving Surgery, but Disparities Remain
June 17th 2015The number of women deciding to have breast-conserving therapy to treat their early-stage breast cancer has been steadily increasing, but these gains are muted for some women due to such factors as insurance status, income, and travel distance to treatment centers.
Better Treatment Options and Follow-Up Improve Outlook for Childhood Cancer Survivors
June 4th 2015Findings from an analysis of more than 34,000 participants in the Childhood Cancer Survivor Study show that among those who have survived at least 5 years, all-cause mortality at 15 years after diagnosis dropped by half from 12.4% to 6%.
New Trial to Expand Patient Access to Off-Label Use of Targeted Drugs for Many Types of Cancer
June 1st 2015ASCO's first-ever clinical trial aims to match patients who have run out of treatment options with therapies that are FDA-approved to treat tumors with their genetic variant but for a different type of cancer.
Novel Oral Agent Palbociclib Stalls Progression in HR-Positive Breast Cancer
May 31st 2015Adding palbociclib (Ibrance) to standard fulvestrant more than doubled progression-free survival in pretreated patients with HR-positive, HER2-negative breast cancer, according to study results presented at the 2015 ASCO Annual Meeting.
Survey Examines What's Driving Patient Decisions to Use Complementary Therapies
May 28th 2015Complementary and alternative therapies like yoga and acupuncture are becoming more popular among cancer patients and survivors to help ease symptoms like pain, fatigue, and distress, but what drives-and deters-the use of these integrative therapies is not well understood.
For Survivors of Breast Cancer, Weight Training Helps Fend Off Physical Decline
May 26th 2015Weight training was shown to help stave off deterioration of physical function in breast cancer survivors, conferring a benefit twice that of women in a control group who did not participate in the weight-lifting intervention.
PSA Screening Declines, Especially Among Men Most Likely to Benefit
May 18th 2015When the United States Preventive Services Task Force (USPSTF) recommended against routine PSA screening for early detection of prostate cancer in May 2012, it caused a sea change in practice patterns among primary care physicians.